Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1197, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Celecoxib: increased risk of myocardial infarction
Inpharma, Vol. 1, Iss. 1528, 2006-01 ,pp. :
Access to resources
Recommend
Increased CV risk with glucocorticoids in Cushing's
Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. :
Lowest effective dosages of celecoxib need to be determined
Reactions Weekly, Vol. 1, Iss. 1073, 2005-01 ,pp. :
COX-2 inhibitors: increased risk of CV events?
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Inhaled anticholinergics: increased risk of major adverse CV events?
Inpharma, Vol. 1, Iss. 1658, 2008-01 ,pp. :